環球醫療(02666.HK)首季未經審核純利按年增9%
環球醫療(02666.HK)公布截至今年3月底止第一季未經審核營運概要,收入按年增加約15%,普通股持有人應佔期內溢利按年增加約9%。
集團表示,其所管理的成員醫療機構第一季受多地疫情影響,核酸檢測工作大量增加,致使總診療人次按年明顯增長,剔除核酸人次後按年增幅約10%;出院人次受疫情影響,按年增加僅3%;體檢人次按年增幅約25%;合計醫療業務收入按年增幅約8%。
醫院集團整體營運效益今年1月受陝西疫情影響最為明顯,2-3月陸續開始逐漸恢復。集團預計,今年第二季初期全國多地疫情將為醫院集團的經營帶來一定影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.